CompoAtlas

KOTOR SILICE BUVABLE

Food supplement declared in France, declaration No 2019-7-730, decision dated 11 July 2019

KOTOR SILICE BUVABLE is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
LABORATOIRE KOTORPHARMA
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Flacon
Daily dose
pour l'adulte : 30 ml
Directions for use
pour l'adulte : prendre 30 ml de préférence le matin à jeun, dilués dans le même volume d'eau.
Not recommended for (according to the manufacturer)
Femmes allaitantes, Femmes enceintes

Declaration 164698, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Urtica dioica L.Parties aériennesAutre extrait fluide150 mg
Equisetum arvense L.Parties aériennesExtrait sec aqueux90 mg
Bambusa bambos (L.) VossExsudatExtrait sec aqueux33 mg

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Acide siliciqueSiliciumpas de limite (données insuffisantes)aucune dose fixée

Additives

E202

Other ingredients

eau, maltodextrine

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging

Label warnings

Déconseillé aux femmes enceintes ou allaitantes.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

List recorded in 2019. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line